CD8 T cells, after recognition of tumor-specific antigens, work through multiple mechanisms to confer anti-tumor activity, including the release of cytokines, granzyme B, and perforin or by engaging death receptor ligands (61) (Figure 2). Here, CD8A is linked to neoplasm.